BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Phase II
VentiRx Pharmaceuticals, Inc. Announces The Completion Of Patient Enrollment In Randomized, Placebo-Controlled Phase 2 Trial Of VTX-2337 In Combination With Pegylated-Liposomal Doxorubicin In Platinum-Resistant Ovarian Cancer 4/17/2014 12:08:52 PM    More...
Nuvilex Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial 4/17/2014 10:28:43 AM    More...
Galapagos NV (GLPG.BR) Release: GSK2586184 Met Primary Endpoint In Phase 2a Psoriasis Study 4/17/2014 9:36:13 AM    More...
Islet Sciences Announces Positive 12-Week Phase 2 Clinical Results For SGLT2 Inhibitor Remogliflozin Etabonate 4/17/2014 9:22:48 AM    More...
ARCA biopharma Announces Screening Of First Patient In Phase 2B/3 Clinical Trial Evaluating Gencaro In Atrial Fibrillation 4/17/2014 8:59:12 AM    More...
Theravance, Inc. (THRX) Announces Initiation Of Phase 2b Study With TD-4208, An Investigational LAMA For The Treatment Of COPD 4/15/2014 10:12:18 AM    More...
Akebia Therapeutics, Inc. (AKBA) Announces Completion Of Enrollment In Its Phase 2b Clinical Study Of AKB-6548 4/15/2014 8:59:54 AM    More...
GlycoMimetics, Inc. (GLYC) Announces Presentation Of Data On Rivipansel (GMI-1070) In Combination With Current FDA-Approved Treatment For Sickle Cell Disease 4/14/2014 9:45:15 AM    More...
Repros Therapeutics Inc. (RPRX) Fully Enrolls First Of Two Previously Announced Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel 4/14/2014 9:14:57 AM    More...
Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study 4/14/2014 7:19:17 AM    More...
Lexicon Pharmaceuticals, Inc. (LXRX)'s LX4211 Achieves Positive Results In Type 1 Diabetes Clinical Trial 4/14/2014 6:24:49 AM    More...
Final Data From The Phase 2 COSMOS Study Of Janssen Research & Development's Once-Daily Simeprevir In Combination With Sofosbuvir Presented At The International Liver Congress™ 2014 Of The European Association For The Study Of The Liver (EASL) 4/14/2014 6:33:02 AM    More...
San Diego's Celladon Corporation Grabs FDA's “Breakthrough Therapy” Status for Gene Therapy 4/10/2014 7:40:33 AM    More...
Beware Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK)'s Hepatitis C Combo Pill Impresses In Phase 2 Trial 4/10/2014 6:05:24 AM    More...
FDA Orders Halozyme Therapeutics, Inc. (HALO) To Halt Pancreatic Cancer Study 4/10/2014 6:15:25 AM    More...
1234567
 

//-->